Cramer: Allergan reveals new tactic to stoke value
July 09, 2014 at 18:36 PM EDT
In his ongoing quest to fend off a hostile takeover attempt, has Allergan CEO David Pyott got something powerful up his sleeve?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.